Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis

苏林达克 医学 家族性腺瘤性息肉病 胃肠病学 安慰剂 内科学 直肠息肉 结直肠癌 直肠 癌症 非甾体 病理 替代医学
作者
Francis M. Giardiello,Stanley R. Hamilton,Anne J. Krush,Steven Piantadosi,Linda M. Hylind,Paul Celano,Susan V. Booker,Chelsea Robinson,G. Johan A. Offerhaus
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:328 (18): 1313-1316 被引量:1820
标识
DOI:10.1056/nejm199305063281805
摘要

BACKGROUND: Familial adenomatous polyposis is an autosomal dominant disorder characterized by the formation of hundreds of colorectal adenomas and eventual colorectal cancer. Administration of the nonsteroidal antiinflammatory drug sulindac has been followed by regression of polyps in patients with this disorder, but no controlled trial of this drug in patients who have not had surgery has been reported. METHODS: We conducted a randomized, double-blind, placebo-controlled study of 22 patients with familial adenomatous polyposis, including 18 who had not undergone colectomy. The patients received sulindac at a dose of 150 mg orally twice a day for nine months or identical-appearing placebo tablets. The number and size of the polyps were evaluated every three months for one year. RESULTS: A statistically significant decrease in the mean number of polyps and their mean diameter occurred in patients treated with sulindac, as compared with those given placebo. When treatment was stopped at nine months, the number of polyps had decreased to 44 percent of base-line values and the diameter of the polyps to 35 percent of base-line values (P = 0.014 and P < 0.001, respectively, for the comparison with the changes in the group given placebo). No patient had complete resolution of polyps. Three months after treatment with sulindac was stopped, both the number and the size of the polyps increased in sulindac-treated patients but remained significantly lower than the values at base line. No side effects from sulindac were noted. CONCLUSIONS: Sulindac reduces the number and size of colorectal adenomas in patients with familial adenomatous polyposis, but its effect is incomplete, and it is unlikely to replace colectomy as primary therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
披日悬光完成签到,获得积分10
刚刚
东风的应助被胡萝卜卜采纳,获得10
刚刚
刚刚
无花果的应助被予诺采纳,获得10
刚刚
复杂夜梦完成签到,获得积分10
1秒前
1秒前
小蘑菇的应助被wy采纳,获得10
1秒前
阿北洛完成签到,获得积分10
2秒前
华仔的应助被优雅网络采纳,获得10
3秒前
赘婿的应助被luoshiwen采纳,获得10
3秒前
tangerine完成签到,获得积分10
4秒前
忧虑的靖巧完成签到 ,获得积分0
4秒前
shengjiangtai完成签到 ,获得积分10
4秒前
victor1995888发布了新的文献求助10
5秒前
ZBH完成签到,获得积分10
6秒前
6秒前
要减肥的安柏完成签到 ,获得积分10
7秒前
8秒前
东风的应助被花花采纳,获得10
8秒前
李天王发布了新的文献求助10
8秒前
yy完成签到,获得积分10
9秒前
9秒前
9秒前
cdercder的应助被胡萝卜卜采纳,获得10
9秒前
9秒前
11秒前
LingYue发布了新的文献求助10
11秒前
勤劳的乐安完成签到,获得积分10
11秒前
11秒前
WYL发布了新的文献求助10
12秒前
李健的应助被雨季采纳,获得10
12秒前
12秒前
暴躁的店员完成签到 ,获得积分20
12秒前
SIMON发布了新的文献求助10
12秒前
FionaZhang发布了新的文献求助10
12秒前
13秒前
cdercder的应助被科研助理795采纳,获得10
14秒前
TomCat发布了新的文献求助10
14秒前
阿里卡多完成签到 ,获得积分10
15秒前
WYL发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193348
求助须知:如何正确求助?哪些是违规求助? 9579548
关于积分的说明 21866040
捐赠科研通 7792906
什么是DOI,文献DOI怎么找? 3437242
关于科研通互助平台的介绍 2560702
邀请新用户注册赠送积分活动 2484066